Development and validation of an intraoperative imaging agent for the peripheral nervous system
周围神经系统术中显像剂的开发和验证
基本信息
- 批准号:10063737
- 负责人:
- 金额:$ 54.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-15 至 2024-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAmericanAnalgesicsAnimalsApplications GrantsAttentionBODIPYBindingBinding ProteinsBiologicalBloodBlood PressureCanis familiarisCardiacCardiovascular PhysiologyChronicClinicClinicalClinical TrialsContrast MediaDataDevelopmentDiseaseDisulfidesDoseDrug KineticsElectrocardiogramElectrophysiology (science)ExcisionFamily suidaeFluorescent DyesFoundationsFutureGoalsGrantHeartHepatocyteHumanIatrogenesisImageImage-Guided SurgeryIndividualInjectableInjectionsInjuryInterventionIntravenousIntuitionKnockout MiceLabelLeadLengthLesionLibrariesLocationMalignant - descriptorMaximum Tolerated DoseMedicalMindModelingModificationMonitorMorbidity - disease rateMusMuscleMuscle fasciculationMuscular AtrophyNerveNerve FibersNerve TissueNervous System TraumaNeuronsNeuropathyNoiseNude MiceOperative Surgical ProceduresOxygenPalpationParalysedPatientsPeptidesPerformancePeripheralPeripheral NervesPeripheral Nervous SystemPeripheral nerve injuryPeruPeruvianPharmacodynamicsPhase I Clinical TrialsPhysiologicalPhysiologyPlant RootsPlasma ProteinsPreparationPropertyReactionRecurrent Laryngeal NerveResearch ProposalsRespiratory physiologyRiskRodentSCN1A proteinSerumSignal TransductionSodium ChannelSpecificityStructureSurgeonSurgical OncologyTestingTimeTissuesToxic effectToxicologyTracerTransgenic OrganismsTranslatingTraumaTraumatic injuryUpper ExtremityValidationVenomsVisualWhole Bloodallodyniabaseclinical practicecohortdesignexperimental studyfluorescence imagingfluorophoreiatrogenic injuryimaging agentimaging systemimprovedin vivoin vivo imaging systeminhibitor/antagonistintravenous administrationlead candidatelipid solubilityloss of functionmalignant mouth neoplasmmembernear infrared dyenerve injurynovelpainful neuropathypatch clamppreservationresidencerespiratoryscaffoldsciatic nerveside effectstandard of caresurgery outcometumorvectorvirtual
项目摘要
Project Summary/Abstract
Twenty million Americans suffer from peripheral nerve injury caused by trauma and medical disorders, resulting
in a broad spectrum of potentially debilitating side effects. In one out of four cases, patients identify surgery as
the root cause of their nerve injury. Particularly during tumor resections or after traumatic injuries, tissue distortion
and poor visibility can challenge a surgeon's ability to precisely locate and preserve peripheral nerves. Intuitively,
surgical outcomes would improve tremendously if nerves could be highlighted using an exogeneous contrast
agent. In clinical practice, however, the current standard of care – visual examination and palpation – remains
unchanged.
The inability of surgeons to identify nerves during surgery represents an immense unmet clinical need, which we
propose to address within this application. We will develop and validate a translational fluorescent imaging agent
for the peripheral nervous system. In preparation for a clinical trial, we will show in mice and large animals that
the agent is safe for use in humans. Specifically, this proposal centers on Hsp1a, a peptide which we isolated
from the venom of a Peruvian tarantula, Homoeomma Spec. Peru, and which we found to be highly specific for
human Nav1.7. It has been shown that Nav1.7 is highly expressed in human peripheral nerve tissue. We believe
that a fluorescent Hsp1a will have tremendous value as an injectable, intraoperative guide during surgery, and
that the agent will provide surgeons with additional contrast, reducing iatrogenic injury and therefore surgical
morbidity.
To achieve this goal, we have assembled three specific aims (SAs), each of which will explore a distinct goal
toward showing that fluorescent Nav1.7 tracers can be translated to the clinic. In SA1, and supported by our
proof-of-principle data, we will synthesize a library of fluorescently labeled Hsp1a derivatives (n = 20), featuring
different fluorophores, attachment points and linker lengths. For all derivatives, we will determine the IC50 values
against Nav1.7 using patch-clamp electrophysiology; in SA2, pharmacokinetics and in vivo performance will be
determined using Nav1.7 expressing, tumor-bearing athymic nude mice and Nav1.7 deficient Scn9atm1Dgen/J mice.
For the most promising tracers (n = 3, based on IC50 and signal/noise ratios), we will test the minimum detectable
dose in cohorts of pigs. In SA3, we will interrogate the pharmacodynamic properties of the most promising Hsp1a
peptides. We will determine the maximum tolerated doses in mice while monitoring cardiovascular and
respiratory function. For the lead candidate, we will perform a 2-species GLP toxicity study (mice and dogs). If
successful, the current research proposal and generated data will form the foundation of a clinical phase I trial
with Hsp1a in oral cancer.
项目总结/摘要
2000万美国人患有由创伤和医疗障碍引起的外周神经损伤,
一系列潜在的使人衰弱的副作用在四分之一的病例中,患者将手术视为
他们神经损伤的根本原因特别是在肿瘤切除术或创伤性损伤后,
并且可见性差会挑战外科医生精确定位和保护周围神经的能力。直观地,
如果可以使用外源性对比剂突出神经,
剂然而,在临床实践中,目前的护理标准-视觉检查和触诊-仍然是
不变
外科医生无法在手术过程中识别神经代表了巨大的未满足的临床需求,
建议在本申请中解决。我们将开发和验证一种翻译荧光成像剂
对于周围神经系统来说。为了准备临床试验,我们将在小鼠和大型动物中证明,
该试剂用于人类是安全的。具体地说,这个建议集中在Hsp 1a上,这是我们分离的一种肽,
来自秘鲁狼蛛的毒液,秘鲁种,我们发现它对
人Nav1.7。已经显示Nav1.7在人外周神经组织中高度表达。我们认为
荧光Hsp 1a作为手术期间可注射的术中引导物将具有巨大的价值,并且
该试剂将为外科医生提供额外的造影剂,减少医源性损伤,
发病率
为了实现这一目标,我们收集了三个具体目标(SA),每个目标都将探索一个独特的目标
显示荧光Nav1.7示踪剂可以应用于临床。在SA 1中,并由我们的
为了验证原理数据,我们将合成荧光标记的Hsp 1a衍生物库(n = 20),其特征在于
不同的荧光团、连接点和连接体长度。对于所有衍生物,我们将测定IC 50值
使用膜片钳电生理学对Nav1.7进行检测;在SA 2中,将对药代动力学和体内性能进行检测。
使用表达Nav1.7的荷瘤无胸腺裸鼠和Nav1.7缺陷Scn 9atm 1Dgen/J小鼠测定。
对于最有希望的示踪剂(n = 3,基于IC 50和信噪比),我们将测试最小可检测浓度。
猪群中的剂量。在SA 3中,我们将询问最有前途的Hsp 1a的药效学特性
缩氨酸我们将确定小鼠的最大耐受剂量,同时监测心血管和
呼吸功能对于主要候选药物,我们将进行2种GLP毒性研究(小鼠和犬)。如果
如果成功,目前的研究方案和产生的数据将构成临床I期试验的基础
Hsp 1a在口腔癌中的作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas Reiner其他文献
Thomas Reiner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas Reiner', 18)}}的其他基金
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy
用于诊断和治疗的放射性碘标记多功能 PARP1 成像探针
- 批准号:
9177196 - 财政年份:2016
- 资助金额:
$ 54.22万 - 项目类别:
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy
用于诊断和治疗的放射性碘标记多功能 PARP1 成像探针
- 批准号:
9306072 - 财政年份:2016
- 资助金额:
$ 54.22万 - 项目类别:
Bioorthogonal Strategies for Targeted PET Imaging Probe Development
靶向 PET 成像探针开发的生物正交策略
- 批准号:
8487906 - 财政年份:2013
- 资助金额:
$ 54.22万 - 项目类别:
Bioorthogonal Strategies for Targeted PET Imaging Probe Development
靶向 PET 成像探针开发的生物正交策略
- 批准号:
8829003 - 财政年份:2013
- 资助金额:
$ 54.22万 - 项目类别:
Bioorthogonal Strategies for Targeted PET Imaging Probe Development
靶向 PET 成像探针开发的生物正交策略
- 批准号:
8643230 - 财政年份:2013
- 资助金额:
$ 54.22万 - 项目类别:
相似海外基金
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348998 - 财政年份:2025
- 资助金额:
$ 54.22万 - 项目类别:
Standard Grant
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348999 - 财政年份:2025
- 资助金额:
$ 54.22万 - 项目类别:
Standard Grant
Collaborative Research: Ionospheric Density Response to American Solar Eclipses Using Coordinated Radio Observations with Modeling Support
合作研究:利用协调射电观测和建模支持对美国日食的电离层密度响应
- 批准号:
2412294 - 财政年份:2024
- 资助金额:
$ 54.22万 - 项目类别:
Standard Grant
Conference: Doctoral Consortium at Student Research Workshop at the Annual Conference of the North American Chapter of the Association for Computational Linguistics (NAACL)
会议:计算语言学协会 (NAACL) 北美分会年会学生研究研讨会上的博士联盟
- 批准号:
2415059 - 财政年份:2024
- 资助金额:
$ 54.22万 - 项目类别:
Standard Grant
Conference: Polymeric Materials: Science and Engineering Division Centennial Celebration at the Spring 2024 American Chemical Society Meeting
会议:高分子材料:美国化学会 2024 年春季会议科学与工程部百年庆典
- 批准号:
2415569 - 财政年份:2024
- 资助金额:
$ 54.22万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346565 - 财政年份:2024
- 资助金额:
$ 54.22万 - 项目类别:
Standard Grant
REU Site: Research Experiences for American Leadership of Industry with Zero Emissions by 2050 (REALIZE-2050)
REU 网站:2050 年美国零排放工业领先地位的研究经验 (REALIZE-2050)
- 批准号:
2349580 - 财政年份:2024
- 资助金额:
$ 54.22万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346564 - 财政年份:2024
- 资助金额:
$ 54.22万 - 项目类别:
Standard Grant
Conference: Latin American School of Algebraic Geometry
会议:拉丁美洲代数几何学院
- 批准号:
2401164 - 财政年份:2024
- 资助金额:
$ 54.22万 - 项目类别:
Standard Grant
Conference: North American High Order Methods Con (NAHOMCon)
会议:北美高阶方法大会 (NAHOMCon)
- 批准号:
2333724 - 财政年份:2024
- 资助金额:
$ 54.22万 - 项目类别:
Standard Grant